Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

GeneDx Holdings Corp

WGS ✓ COMPLIANT ☆ Track — members

Nasdaq · Healthcare · Healthcare Facilities & Services ·

USA Mid Cap Analyst: BUY

Last Close

$85.19

▼ -2.15%

Market Cap $2.54B · Vol 141.22K

Key Metrics

P/E Ratio

N/A

FWD: 89.20

Market Cap

$2.54B

Mid Cap

Div Yield

N/A

EPS Growth

-92.98%

YoY

RSI (14)

71.81

Momentum

Beta

2.00

vs Market

52W High

$170.31

49.98% below

52W Low

$32.22

164.40% above

Volume

141.22K

Avg 268.90K

P/B

12.34

Price-to-book

ROE

N/A

Return on equity

Free Float

87.75%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, GeneDx Holdings Corp (WGS) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does WGS pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

+10.08%

+44.15%

+80.07%

+5.56%

YTD

-34.50%

-33.79%

+1,904.47%

-72.42%

Financials & Valuation

TTM · Annual

Total Revenue	$427.54M
Net Income	$-21,021,000.00
Revenue Growth (YoY)	+11.44%
Gross Margin	69.74%
Operating Margin	-3.06%
Net Profit Margin	-4.92%
ROE	N/A
ROA · ROIC	-4.48% · N/A

P/E Ratio	N/A
Forward P/E (FY1)	89.20
PEG Ratio	N/A
P/S	8.71
P/B	12.34
P/FCF	261.19
EPS Growth	-92.98%
Outstanding Shares	29.82M

Technical Indicators

50-Day SMA	$68.25
200-Day SMA	$87.01
RSI (14)	71.81
Beta	2.00
52-Week High	$170.31
52-Week Low	$32.22

Volume Today	141.22K
Avg Daily Volume (30D)	268.90K
Relative Volume	0.53x
Volatility (10D)	50.12
Volatility (30D)	65.28
Free Float	87.75%

Analyst Consensus

BUY

Current Price $85.19

Mean Target $90.44

52W Low$32.22 52W High$170.31

Current

Target

$32.22 $170.31

Current Analyst target

+6.17% upside potential · 10 analysts

Identifiers

ExchangeNasdaq

FIGIBBG00XDHY5R7

ISINUS81663L2007

CountryUnited States of America

Sub-IndustryMedical & Diagnostic Laboratories

Earnings DateOct 26, 2026

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

NTRA Natera Inc -1.30% LH Labcorp Holdings Inc +0.89% RDNT RadNet Inc -2.77% LALPATHLAB.NS Dr. Lal PathLabs Ltd -0.55% NEO Neogenomics Inc -3.36%

Company Profile

GeneDx Holdings Corp. is a genomics company. The Company operates, through its subsidiary, GeneDx, LLC, which is focused on exome and genome tests that translate complex genomic data into clinical answers that unlock personalized health plans, accelerate drug discovery, and improve health system efficiencies. It operates through the GeneDx segment, which primarily provides pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing and, to a lesser extent, data and information services. Genomic sequencing tests include whole genome sequencing, whole exome sequencing, prenatal genetic testing, targeted testing, pediatric neurology, general pediatrics, geneticists and genetic counsellors, and others. It offers a menu of targeted variant testing options to meet the needs of families and healthcare providers. Its subsidiary, Fabric Genomics, Inc., specializes in artificial intelligence-powered genomic interpretation.